Sentences with phrase «journal clinical cancer research»

Vitamin A may help protect against sun damage, according to a 2004 study in the journal Clinical Cancer Research, and vitamins C and E are well - known for their beauty benefits.

Yes the first paper is titled «Effects of Dosing Condition on the Oral Bioavailability of Green Tea Catechins after Single - Dose Administration of Polyphenon E in Healthy Individuals» and is in the June 15, 2005 issue of the journal Clinical Cancer Research.

So instead of always being harmful, particularly in men, plant - based phytoestrogens may serve the functional purpose of blocking harmful estrogens from feeding hormone - related cancers, as illustrated in several studies, including a 2005 study published in the journal Clinical Cancer Research.

The patient's case was one of a handful described last week in the journal Clinical Cancer Research.

The study has already been published online and will soon appear in the print edition of the technical journal Clinical Cancer Research.

The results were published recently in the journal Clinical Cancer Research.

In 2010, researchers from the University of Michigan Comprehensive Cancer Center published a study in the journal Clinical Cancer Research showing that sulforaphane had the ability to kill breast cancer stem cells in mice and in lab cultures, and it also prevented the growth of new tumor cells.

Not exact matches

Like much of the research on how diet affects health, the research on the link between meat and cancer has enough ambiguity that it's possible to cherry - pick a research list that supports either position, but many reviews of research on the best - established link between meat and cancer — colorectal cancer — find, as this 2014 review published in the American Journal of Clinical Nutrition does, that there is a convincing association between meat eating and colorectal cancer.

Writing in the current issue of the journal Cancer Research, the team notes, however, that a combination of therapies will most likely be required to obtain significant clinical results.

In a letter to the New England Journal of Medicine, a Massachusetts General Hospital (MGH) research team reports a remarkable treatment response in a patient participating in a clinical trial of a novel immune - system - based cancer therapy.

The work is published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

Reporting in the Journal of Clinical Investigation Insights, a team led by senior author Andrea Facciabene, PhD, a research assistant professor of Radiation Oncology and Obstetrics / Gynecology, found that the effectiveness of adoptive T cell therapy (ACT) in mice with cancer is significantly affected by differences in the natural makeup of gut bacteria and treatment with antibiotics.

The research, funded by the National Institutes of Health, the American Cancer Society, and the Cancer Prevention Research Institute of Texas, is published in The Journal of Clinical Investresearch, funded by the National Institutes of Health, the American Cancer Society, and the Cancer Prevention Research Institute of Texas, is published in The Journal of Clinical InvestResearch Institute of Texas, is published in The Journal of Clinical Investigation.

The study is published in the journal Cancer Cell, with funding for the UK research team coming from the Kimmel Cancer Foundation, Cancer Research UK, The Marie Curie Actions Programme and a Scottish Senior Clinical Research Felresearch team coming from the Kimmel Cancer Foundation, Cancer Research UK, The Marie Curie Actions Programme and a Scottish Senior Clinical Research FelResearch UK, The Marie Curie Actions Programme and a Scottish Senior Clinical Research FelResearch Fellowship.

The study results were published online June 1 by the journal Breast Cancer Research and Treatment, and were presented June 4 at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago.

She is a former member the editorial board of the Journal of Clinical Oncology, is currently on the editorial board of Cancer Research and the Breast Journal.

Peer Rewiewing Ad hoc reviewer for several journals including: Science, Nature Medicine, Nature Immunology, Nature Reviwes in Immunology, Immunity, Journal Experimental Medicine, Blood, Journal of Immunology, European Journal of Immunology, Immunology, Clinical and Experimental Immunology, Journal of Leukocyte Biology, PLoS Medicine, PLoS One, Molecular Medicine, Clinical Cancer Research, British Journal of Cancer, Cancer Research, Journal of Infectious Diseases, Infection and Immunity.

Cancer Immunity was an open access, peer - reviewed journal of the Cancer Research Institute (CRI) that published laboratory and clinical research papers on the immune response to cancer untilCancer Immunity was an open access, peer - reviewed journal of the Cancer Research Institute (CRI) that published laboratory and clinical research papers on the immune response to cancer untilCancer Research Institute (CRI) that published laboratory and clinical research papers on the immune response to cancer untResearch Institute (CRI) that published laboratory and clinical research papers on the immune response to cancer untresearch papers on the immune response to cancer untilcancer until 2013.

He has contributed to more than 130 peer - reviewed publications in journals, has participated in grant review panels nationally (NIH and NSF) and internationally and is member of the Editorial Boards of the American Journal of Hematology, Clinical Chemistry, Human Mutation, European Journal of Human Genetics, Journal of Cancer Therapeutics and Research and Journal of Genomics and Proteomics.

The author or co-author of more than 450 published papers, review articles, book chapters, editorials and abstracts, Ultmann has served on the editorial boards of most of the major cancer journals, including Cancer Research, the Annals of Internal Medicine, the Journal of Clinical Oncology, and cancer journals, including Cancer Research, the Annals of Internal Medicine, the Journal of Clinical Oncology, and Cancer Research, the Annals of Internal Medicine, the Journal of Clinical Oncology, and Blood.

He is Deputy Editor of Clinical Cancer Research and member of the Editorial Board of Cancer Cell and six other peer - reviewed journals.

Despite 25 years of intense research and thousands of clinical trials of promising new cancer therapies, there has been only scattered progress in treatment since President Richard Nixon declared the «War on Cancer» in December 1971, report two researchers from the University of Chicago in a Special Article in the May 29, 1997 issue of the New England Journal of Medcancer therapies, there has been only scattered progress in treatment since President Richard Nixon declared the «War on Cancer» in December 1971, report two researchers from the University of Chicago in a Special Article in the May 29, 1997 issue of the New England Journal of MedCancer» in December 1971, report two researchers from the University of Chicago in a Special Article in the May 29, 1997 issue of the New England Journal of Medicine.

Skapek is a frequent reviewer for several publications, including Pediatrics, Journal of Cell Biology and Clinical Cancer Research.

May 29, 1997 News from the cancer front: glass remains half empty Despite 25 years of intense research and thousands of clinical trials of promising new cancer therapies, there has been only scattered progress in treatment since President Richard Nixon declared the «War on Cancer» in December 1971, report two researchers from the University of Chicago in a Special Article in the May 29, 1997, issue of the New England Journal of Medcancer front: glass remains half empty Despite 25 years of intense research and thousands of clinical trials of promising new cancer therapies, there has been only scattered progress in treatment since President Richard Nixon declared the «War on Cancer» in December 1971, report two researchers from the University of Chicago in a Special Article in the May 29, 1997, issue of the New England Journal of Medcancer therapies, there has been only scattered progress in treatment since President Richard Nixon declared the «War on Cancer» in December 1971, report two researchers from the University of Chicago in a Special Article in the May 29, 1997, issue of the New England Journal of MedCancer» in December 1971, report two researchers from the University of Chicago in a Special Article in the May 29, 1997, issue of the New England Journal of Medicine.

She also is a reviewer for numerous journals, including the New England Journal of Medicine, the Journal of Clinical Investigation, Cancer Research and the Journal of Clinical Oncology.

She also is a reviewer for many prominent journals, including the New England Journal of Medicine and Cancer Research, and is a member of the Journal of Clinical Oncology editorial board.

Richardson serves on the Editorial Board of the Journal of Clinical Oncology, Clinical Cancer Research, and the British Journal of Hematology.

Dr. Meszoely has contributed to several research journals, including the Annals of Surgical Oncology, Cancer Cell and The Cancer Journal, and is a member of the American Society of Clinical Oncology, American Society of Breast Surgeons, American Society of Clinical Research, American College of Surgeons and the Society of Surgical Oresearch journals, including the Annals of Surgical Oncology, Cancer Cell and The Cancer Journal, and is a member of the American Society of Clinical Oncology, American Society of Breast Surgeons, American Society of Clinical Research, American College of Surgeons and the Society of Surgical OResearch, American College of Surgeons and the Society of Surgical Oncology.

Clinical cancer research: an official journal of the American Association for Cancer Research 2017; 23; 11; 2617 cancer research: an official journal of the American Association for Cancer Research 2017; 23; 11; 261research: an official journal of the American Association for Cancer Research 2017; 23; 11; 2617 Cancer Research 2017; 23; 11; 261Research 2017; 23; 11; 2617 - 2629

Antibodies to a high - risk type of human papillomavirus (HPV16) could help detect oropharyngeal (1) cancer several years before the clinical onset of the disease, reveals a new study from the International Agency for Research on Cancer (IARC) in cooperation with the German Cancer Research Center (DKFZ) and the United States National Cancer Institute (NCI) in an article published online today by the Journal of Clinical Onccancer several years before the clinical onset of the disease, reveals a new study from the International Agency for Research on Cancer (IARC) in cooperation with the German Cancer Research Center (DKFZ) and the United States National Cancer Institute (NCI) in an article published online today by the Journal of Clinical Oclinical onset of the disease, reveals a new study from the International Agency for Research on Cancer (IARC) in cooperation with the German Cancer Research Center (DKFZ) and the United States National Cancer Institute (NCI) in an article published online today by the Journal of Clinical OncCancer (IARC) in cooperation with the German Cancer Research Center (DKFZ) and the United States National Cancer Institute (NCI) in an article published online today by the Journal of Clinical OncCancer Research Center (DKFZ) and the United States National Cancer Institute (NCI) in an article published online today by the Journal of Clinical OncCancer Institute (NCI) in an article published online today by the Journal of Clinical OClinical Oncology.

The findings were reported in an issue of Clinical Cancer Research, a journal of the American Association for Cancer Research.

Choosing to regularly eat lycopene - rich foods, such as pink grapefruit, and drink green tea may greatly reduce a man's risk of developing prostate cancer, suggests research published the Asia Pacific Journal of Clinical Nutrition (Jian L, Lee AH, et al..)

A City Herbal: Lore, Legend, & Uses of Common Weeds Acta Pharmaceutica Acta Pharmaceutica Sinica Acta physiologica et pharmacologica Bulgarica Advances in Applied Science Research Advances in Food and Nutrition Research Advances in New Crops African Journal of Traditional, Complementary, and Alternative Medicines Agricultural Ecological Atlas of Russia and Neighboring Countries Agricultural Economics Agricultural Economics and Agribusiness Alcohol and Temperance in Modern History Alimentary Pharmacology & Therapeutics Aloe Vera: Nature's Silent Healer Alternative Field Crops Manual Alternative Medicine Review American Cancer Society American Chemical Society American Heart Association American Journal of Botany American Journal of Chinese Medicine American Journal of Clinical Dermatology American Journal of Clinical Nutrition American Journal of Gastroenterology American Journal of Therapeutics American Midland Naturalist Anais da Academia Brasileira de Ciências Analytical and Bioanalytical Chemistry Annals of Botany

SOURCES: Claudio Anasetti, M.D., professor, medicine, University of South Florida, and senior member, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Fla.; Frederick Appelbaum, M.D., director, clinical research, Fred Hutchinson Cancer Research Center, Seattle; Oct. 18, 2012, New England Journal of Research Institute, Tampa, Fla.; Frederick Appelbaum, M.D., director, clinical research, Fred Hutchinson Cancer Research Center, Seattle; Oct. 18, 2012, New England Journal of research, Fred Hutchinson Cancer Research Center, Seattle; Oct. 18, 2012, New England Journal of Research Center, Seattle; Oct. 18, 2012, New England Journal of Medicine

Whether the issue is clinical research, cancer clusters, or global warming, corporate interests can hide behind the credibility of peer - reviewed journals,» says Virginia A. Sharpe, Ph.D., a bioethicist and Director of CSPI's Integrity in Science project which coordinated the initiative.

The National Cancer Institute funded the research that was published online in the Journal of Clinical Oncology.

ASCO's growing roster of cutting - edge journals serves readers as the most credible, authoritative, peer - reviewed resources for significant clinical oncology research and research that informs the delivery of efficient, high - quality cancer care across the globe.

About Blog Cancer Genomics & Proteomics (CGP) is an international peer - reviewed journal designed to publish rapidly high quality articles and reviews on the application of genomic and proteomic technology to basic, experimental and clinical cancer resCancer Genomics & Proteomics (CGP) is an international peer - reviewed journal designed to publish rapidly high quality articles and reviews on the application of genomic and proteomic technology to basic, experimental and clinical cancer rescancer research.